Loading...

Home
ETF
LYRA

LYRA

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

LYRA News

Sanofi Secures EU Approval for Teizeild, Demonstrating Significant Efficacy in Type 1 Diabetes

Jan 16 2026NASDAQ.COM

U.S. Stocks Mixed; Day One Biopharmaceuticals Shares Surge 20%

Jan 12 2026Benzinga

Dow Jones Falls Over 250 Points as Financial Stocks Decline

Jan 12 2026Benzinga

Assertio (ASRT) Exceeds Q3 Earnings and Revenue Projections

Nov 10 2025NASDAQ.COM

Upstream's Innovative Sinus Treatment Reduces Surgical Requirements, Initial Trial Reveals

Sep 02 2025Benzinga

Lyra Therapeutics Posts 85% Q2 Loss Drop

Aug 13 2025NASDAQ.COM

Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates

Aug 08 2025NASDAQ.COM

Insider Sale: President & CEO of $LYRA Sells 1,565 Shares

Jul 15 2025NASDAQ.COM

Lyra Therapeutics Raises $5 Mln In Direct Offering, Eyes $9.8 Mln Via Warrant Exercises

Jun 27 2025NASDAQ.COM

Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Jun 27 2025Newsfilter

Lyra Therapeutics to raise up to $15M via registered direct offering and concurrent private placement, stock falls 22%

Jun 27 2025SeekingAlpha

New Analyst Forecast: $LYRA Given 'Neutral' Rating

Jun 11 2025NASDAQ.COM

HC Wainwright & Co. Maintains Neutral on Lyra Therapeutics, Raises Price Target to $16

Jun 10 2025Benzinga

US Stocks Likely To Open Lower: Expert Highlights Technical Analysis Showing S&P 500's 'Recovery Is Real' And Not A 'Bull Trap' Or 'Bear Market Rally'

Jun 03 2025Benzinga

Nasdaq Surges Over 100 Points Despite Renewed Trade Concerns: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

Jun 03 2025Benzinga

Applied Digital Corp, Meta Platforms, Alphabet, Lyra Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Jun 03 2025Benzinga